Effects of ischemic postconditioning on the hemodynamic parameters and heart nitric oxide levels of hypothyroid rats;Efeito do pós-condicionamento isquêmico na hemodinâmica e nos níveis cardíacos de óxido nítrico em ratos com hipotireoidismo

Arquivos Brasileiros de Cardiologia

Volumn 104, Issue 2, 2014, Pages 136-143

  Jeddi, Sajad ^a,b   Zaman, Jalal ^a,b   Ghasemi, Asghar ^a,b  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Hypothyroidism; Ischemic postconditioning; Nitric Oxide; Rats; Reperfusion

Indexed keywords

CITRATE SYNTHASE; LIOTHYRONINE; NITRIC OXIDE; THYROTROPIN; THYROXINE; THYROID HORMONE;

ACUTE HEART INFARCTION; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONARY ARTERY BLOOD FLOW; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART LEFT VENTRICLE PRESSURE; HEART RATE; HEMODYNAMICS; HYPOTHYROIDISM; ISCHEMIA; ISCHEMIC POSTCONDITIONING; MALE; METABOLITE; NONHUMAN; RAT; REPERFUSION INJURY; WEIGHT CHANGE; ANIMAL; BLOOD; CHEMICALLY INDUCED; HEART MUSCLE; METABOLISM; MYOCARDIAL REPERFUSION INJURY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROCEDURES; REFERENCE VALUE; REPRODUCIBILITY; TIME; TREATMENT OUTCOME; WISTAR RAT;

ANIMALS; HEMODYNAMICS; HYPOTHYROIDISM; ISCHEMIC POSTCONDITIONING; MALE; MYOCARDIAL REPERFUSION INJURY; MYOCARDIUM; NITRIC OXIDE; RATS, WISTAR; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; THYROID HORMONES; TIME FACTORS; TREATMENT OUTCOME;

EID: 84926288894     PISSN: 0066782X     EISSN: 16784170     Source Type: Journal    
DOI: 10.5935/abc.20140181     Document Type: Article

References (33)

1. Hausenloy DJ. Signalling pathways in ischaemic postconditioning. Thromb Haemost.2009; 10(4): 626-34.
2. Hu S, Huang M, Li Z, Jia F, Ghosh Z, Lijkwan MA, et al. MicroRNA-210 as a novel therapy for treatment of ischemic heart disease. Circulation.2010; 122(11 Suppl): S124-31.
3. Silvestri P, Di Russo C, Rigattieri S, Fedele S, Todaro D, Ferraiuolo G, et al. MicroRNAs and ischemic heart disease: towards a better comprehension of pathogenesis, new diagnostic tools and new therapeutic targets. Recent Pat Cardiovasc Drug Discov. 2009; 4(2): 109-18.
4. Yin X, Zheng Y, Zhai X, Zhao X, Cai L. Diabetic inhibition of preconditioning-and postconditioning-mediated myocardial protection against ischemia/ reperfusion injury. Exp Diabetes Res. 2012; 2012: 198048.
5. Mourouzis I, Dimopoulos A, Saranteas T, Tsinarakis N, Livadarou E, Spanou D, et al. Ischemic preconditioning fails to confer additional protection against ischemia-reperfusion injury in the hypothyroid rat heart. Physiol Res.2009; 58(1): 29-38.
6. Pantos C, Malliopoulou V, Mourouzis I, Sfakianoudis K, Tzeis S, Doumba P, et al. Propylthiouracil-induced hypothyroidism is associated with increased tolerance of the isolated rat heart to ischaemia-reperfusion. J Endocrinol. 2003; 178(3): 427-35.
7. Rosner B. Fundamentals of biostatistics. 6th ed. Boston: Brooks/Cole; 2005.
8. Siu PM, Donley DA, Bryner RW, Alway SE. Citrate synthase expression and enzyme activity after endurance training in cardiac and skeletal muscles. J Appl Physiol (1985). 2003; 94(2): 555-60.
9. Ohga Y, Sakata S, Takenaka C, Abe T, Tsuji T, Taniguchi S, et al. Cardiac dysfunction in terms of left ventricular mechanical work and energetics in hypothyroid rats. Am J Physiol Heart Circ Physiol. 2002; 283(2): H631-41.
10. Shenoy R, Klein I, Ojamaa K. Differential regulation of SR calcium transporters by thyroid hormone in rat atria and ventricles. Am J Physiol Heart Circ Physiol. 2001; 281(4): H1690-6.
11. Eynan M, Knubuvetz T, Meiri U, Navon G, Gerstenblith G, Bromberg Z, et al. Heat acclimation-induced elevated glycogen, glycolysis, and low thyroxine improve heart ischemic tolerance. J Appl Physiol (1985.) 2002; 93(6): 2095-104.
12. Abe M, Obata H, Tanaka H. Functional and metabolic responses to ischemia in the isolated perfused hypothyroid rat heart. Jpn Circ J. 1992; 56: 671-80.
13. Pantos C, Mourouzis I, Malliopoulou V, Paizis I, Tzeis S, Moraitis P, et al. Dronedarone administration prevents body weight gain and increases tolerance of the heart to ischemic stress: a possible involvement of thyroid hormone receptor alpha1. Thyroid. 2005; 15(1): 16-23.
14. Pantos C, Mourouzis I, Delbruyere M, Malliopoulou V, Tzeis S, Cokkinos DD, et al. Effects of dronedarone and amiodarone on plasma thyroid hormones and on the basal and postischemic performance of the isolated rat heart. Eur J Pharmacol. 2002; 444(3): 191-6.
15. Ravingerova T, Barancik M, Strniskova M. Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology. Mol Cell Biochem. 2003; 247(1-2): 127-38.
16. Pantos C, Malliopoulou V, Varonos DD, Cokkinos DV. Thyroid hormone and phenotypes of cardioprotection. Basic Res Cardiol. 2004; 99(2): 101-20.
17. Ghasemi A, Mehrazin F, Zahediasl S. Effect of nitrate and L-arginine therapy on nitric oxide levels in serum, heart, and aorta of fetal hypothyroid rats. J Physiol Biochem. 2013; 69(4): 751-9.
18. Fan Q, Yang XC, Liu Y, Wang LF, Liu SH, Ge YG, et al. Postconditioning attenuates myocardial injury by reducing nitro-oxidative stress in vivo in rats and in humans. Clin Sci (Lond). 2011; 120(6): 251-61.
19. Ding HL, Zhu HF, Dong JW, Zhu WZ, Yang WW, Yang HT, et al. Inducible nitric oxide synthase contributes to intermittent hypoxia against ischemia/ reperfusion injury. Acta Pharmacol Sin. 2005; 26(3): 315-22.
20. Tao L, Gao E, Hu A, Coletti C, Wang Y, Christopher TA, et al. Thioredoxin reduces post-ischemic myocardial apoptosis by reducing oxidative/nitrative stress. Br J Pharmacol. 2006; 14(3)9: 311-8.
21. Baker JE, Holman P, Kalyanaraman B, Griffith OW, Pritchard KA, Jr. Adaptation to chronic hypoxia confers tolerance to subsequent myocardial ischemia by increased nitric oxide production. Ann N Y Acad Sci. 1999; 874: 236-53.
22. Node K, Kitakaze M, Kosaka H, Komamura K, Minamino T, Inoue M, et al. Increased release of NO during ischemia reduces myocardial contractility and improves metabolic dysfunction. Circulation. 1996; 93(2): 356-64.
23. Brunner F, Maier R, Andrew P, Wolkart G, Zechner R, Mayer B. Attenuation of myocardial ischemia/reperfusion injury in mice with myocyte-specific overexpression of endothelial nitric oxide synthase. Cardiovasc Res. 2003; 57(1): 55-62.
24. Ferdinandy P, Schulz R. Nitric oxide, superoxide, and peroxynitrite in myocardial ischaemia-reperfusion injury and preconditioning. Br J Pharmacol. 2003; 138(4): 532-43.
25. Schulz R, Kelm M, Heusch G. Nitric oxide in myocardial ischemia/ reperfusion injury. Cardiovasc Res. 2004; 61(3): 402-13.
26. Yasmin W, Strynadka KD, Schulz R. Generation of peroxynitrite contributes to ischemia-reperfusion injury in isolated rat hearts. Cardiovasc Res. 1997; 33(2): 422-32.
27. Wang P, Zweier JL. Measurement of nitric oxide and peroxynitrite generation in the postischemic heart. Evidence for peroxynitrite-mediated reperfusion injury. J Biol Chem. 1996; 271(46): 29223-30.
28. Levrand S, Vannay-Bouchiche C, Pesse B, Pacher P, Feihl F, Waeber B, et al. Peroxynitrite is a major trigger of cardiomyocyte apoptosis in vitro and in vivo. Free Radic Biol Med. 2006; 41(6): 886-95.
29. Badalzadeh R, Mohammadi M, Najafi M, Ahmadiasl N, Farajnia S, Ebrahimi H. The additive effects of ischemic postconditioning and cyclosporine-A on nitric oxide activity and functions of diabetic myocardium injured by ischemia/reperfusion. J Cardiovasc Pharmacol Ther. 2012; 17(2): 181-9.
30. Gao Q, Hu JF, Yu Y, Jiang CR, Guan SD, Li ZH. [The role of nitric oxide in ethanol postconditioning induced cardioprotection]. Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2012; 28(1): 9-13.
31. Csonka C, Szilvassy Z, Fulop F, Pali T, Blasig IE, Tosaki A, et al. Classic preconditioning decreases the harmful accumulation of nitric oxide during ischemia and reperfusion in rat hearts. Circulation. 1999; 100(22): 2260-6.
32. Quesada A, Sainz J, Wangensteen R, Rodriguez-Gomez I, Vargas F, Osuna A. Nitric oxide synthase activity in hyperthyroid and hypothyroid rats. Eur J Endocrinol. 2002; 147(1): 117-22.
33. Roberts CG, Ladenson PW. Hypothyroidism. Lancet. 2004; 363(9411): 793-803.